They reported for first time that miR-192 was downregulated in OS cells, and after transfection of a miR-192 mimic into OS cells, they observed an inhibition of cancer progression via miR-192 binding to its specific target, the TCF7 gene [205]. This evidence concerns the gene TCF7 and cancer.